Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Healthy Ageing intranasal oxytocin fMRI study
ACTRN12615001148561Phase 3Completed
- Sponsor
- Australian Catholic University
- Start
- Oct 2015
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of oxytocin and Placebo-COD Research Private Ltd (2 arms), sponsored by Australian Catholic University. Primary endpoint: Functional MRI response to emotional face task. Started Oct 2015; status: completed.
02
Drugs
oxytocinPlacebo-COD Research Private Ltd
Beyond the preview
Go deeper on ACTRN12615001148561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615001148561.